1,809
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Ultrasound-Stimulated Microbubbles Inhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophageal squamous cell carcinoma

, , ORCID Icon, &
Pages 3000-3013 | Received 23 Mar 2021, Accepted 13 May 2021, Published online: 27 Jun 2021

References

  • Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019 Dec 1;5(12):1749–1768. PubMed PMID: 31560378; PubMed Central PMCID: PMCPMC6777271 National Council for Scientific and Technological Development. Dr Haro reports being a contractor for Eli Lilly and Company and receiving personal fees from Lundbeck. Mr Hidru reports receiving grants, personal fees, nonfinancial support, and other support from Adigrat University. Dr Iseh reports receiving nonfinancial support from the Usmanu Danfodiyo University Teaching Hospital and the Institute of Human Virology, Nigeria. Dr Jakovljevic reports receiving grants from the Ministry of Education, Science and Technological Development of the Republic of Serbia. Dr James reports receiving grants from Sanofi Pasteur. Dr Lazarus reports receiving grants and personal fees from AbbVie, Gilead Sciences, and MSD. Dr Meretoja reports receiving grants from the Cancer Foundation Finland. Dr Moradi-Lakeh reports being a consultant for a project funded by Novartis. Dr Postma reports receiving grants from Quintiles and Bayer; personal fees from AbbVie, Astellas, and Pharmerit; grants and personal fees from Bristol-Myers Squibb, AstraZeneca, Sanofi, Novartis, Janssen, GlaxoSmithKline, Pfizer, MSD, and Asc Academics, as well as serving as an advisor for the organization; and earnings from stock in Ingress Health and PAB BV. Dr Savic reports being an employee of the GlaxoSmithKline group of companies and holds restricted shares in the GlaxoSmithKline group of companies. Dr J. Singh reports receiving personal fees from serving as a consultant for Crealta/Horizon, Medisys, Fidia, UBM LLC, Medscape, WebMD, the National Institutes of Health, and the American College of Rheumatology; earnings from stocks in the Amarin Corporation and Viking Therapeutics; and nonfinancial support from serving as a member of OMERACT, the US Department of Veterans Affairs Rheumatology Field Advisory Committee, and committees of the American College of Rheumatology. No other disclosures are reported. eng.
  • Kamangar F, Nasrollahzadeh D, Safiri S; The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017. a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):582–597. PubMed PMID: 32246941; PubMed Central PMCID: PMCPMC7232026.eng.
  • Bray F, Ferlay J, Soerjomataram I,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. PubMed PMID: 30207593.
  • Arnold M, Laversanne M, Brown LM,et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017 Aug;112(8):1247–1255. PubMed PMID: 28585555; eng.
  • Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014 Jun;109(6):822–827. PubMed PMID: 24751582; eng.
  • Liu J, Wang J, Leng Y, et al. Intake of fruit and vegetables and risk of esophageal squamous cell carcinoma: a meta-analysis of observational studies. Int J Cancer. 2013 Jul 15;133(2):473–485. PubMed PMID: 23319052; eng.
  • Qu X, Ben Q, Jiang Y. Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. Ann Epidemiol. 2013 Dec;23(12):762–770.e1. PubMed PMID: 24176821; eng.
  • Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer. Lancet. 2017 Nov 25;390(10110):2383–2396. PubMed PMID: 28648400; eng.
  • Liu X, Zhang Y, Tang LL, et al. Characteristics of radiotherapy trials compared with other oncological clinical trials in the past 10 years. JAMA Oncol. 2018 Aug 1;4(8):1073–1079. PubMed PMID: 29799987; PubMed Central PMCID: PMCPMC6143047 support from Varian Medical Systems. No other disclosures were reported. eng.
  • Delaney G, Jacob S, Featherstone C, et al. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005 Sep 15;104(6):1129–1137. PubMed PMID: 16080176; eng.
  • Citrin DE. Recent developments in radiotherapy. N Engl J Med. 2017 Sep 14;377(11):1065–1075. PubMed PMID: 28902591; eng.
  • Gao X-S. Treatment guideline of radiotherapy for Chinese esophageal carcinoma (draft). Chin J Cancer. 2010 Oct;29(10):855–859. PubMed PMID: 20868554; eng.
  • Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013 Feb 2;381(9864):400–412. PubMed PMID: 23374478; eng.
  • Chen Y, Gao P, Wu T, et al. Organelle-localized radiosensitizers. Chem Commun (Camb). 2020 Sep 15;56(73):10621–10630. PubMed PMID: 32930179; eng.
  • Gill MR, Vallis KA. Transition metal compounds as cancer radiosensitizers. Chem Soc rev. 2019 Jan 21;48(2):540–557. PubMed PMID: 30499573; eng.
  • Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov. 2013 Jul;12(7):526–542. PubMed PMID: 23812271; PubMed Central PMCID: PMCPMC3906736. eng.
  • Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009 Mar 21;54(6):R27–57. PubMed PMID: 19229096; PubMed Central PMCID: PMCPMC2818980. eng.
  • Helfield BA. Review of phospholipid encapsulated ultrasound contrast agent microbubble physics. Ultrasound Med Biol. 2019 Feb;45(2):282–300. PubMed PMID: 30413335; eng.
  • Upadhyay A, Dalvi SV. Microbubble formulations: synthesis, stability, modeling and biomedical applications. Ultrasound Med Biol. 2019 Feb;45(2):301–343. PubMed PMID: 30527395; eng.
  • Huang P, You X, Pan M, et al. A novel therapeutic strategy using ultrasound mediated microbubbles destruction to treat colon cancer in a mouse model. Cancer Lett. 2013 Jul 10;335(1):183–190. PubMed PMID: 23415737; eng.
  • Lin CY, Huang YL, Li JR,et al. Effects of focused ultrasound and microbubbles on the vascular permeability of nanoparticles delivered into mouse tumors. Ultrasound Med Biol. 2010 Sep;36(9):1460–1469. PubMed PMID: 20800173; eng.
  • Sharma D, Giles A, Hashim A, et al. Ultrasound microbubble potentiated enhancement of hyperthermia-effect in tumours. PLoS One. 2019;14(12):e0226475. PubMed PMID: 31851698; PubMed Central PMCID: PMCPMC6919613. eng.
  • Klein J, Tran W, Lai P, et al. Effect of treatment sequencing on the tumor response to combined treatment with ultrasound-stimulated microbubbles and radiotherapy. J Ultrasound Med. 2020 Jun 11;12:2415–2425. PubMed PMID: 32525248; eng. DOI:10.1002/jum.15363.
  • Deng H, Cai Y, Feng Q, et al. Ultrasound-stimulated microbubbles enhance radiosensitization of nasopharyngeal carcinoma. Cell Physiol Biochem. 2018;48(4):1530–1542. PubMed PMID: 30071515; eng.
  • El Kaffas A, Gangeh MJ, Farhat G, et al. Tumour vascular shutdown and cell death following ultrasound-microbubble enhanced radiation therapy. Theranostics. 2018;8(2):314–327. PubMed PMID: 29290810; PubMed Central PMCID: PMCPMC5743550. eng.
  • Bulner S, Prodeus A, Gariepy J, et al. Enhancing checkpoint inhibitor therapy with ultrasound stimulated microbubbles. Ultrasound Med Biol. 2019 Feb;45(2):500–512. PubMed PMID: 30447880; eng.
  • Czarnota GJ, Karshafian R, Burns PN, et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proceedings of the National Academy of Sciences of the United States of America. 2012 Jul 24;109( 30):E2033–41. PubMed PMID: 22778441; PubMed Central PMCID: PMCPMC3409730. eng.
  • Li J, Xi A, Qiao H, et al. Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles. Cancer Lett. 2020 Apr 10;475:92–98. PubMed PMID: 32032678; eng.
  • El Kaffas A, Czarnota GJ. Biomechanical effects of microbubbles: from radiosensitization to cell death. Future oncol (London, England). 2015;11(7):1093–1108. PubMed PMID: 25804124; eng.
  • Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005 Aug;8(2):89–91. PubMed PMID: 16098459; eng.
  • Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest. 2002 Jul;110(1):3–8. PubMed PMID: 12093880; PubMed Central PMCID: PMCPMC151041. eng.
  • McDannold NJ, King RL, Jolesz FA,et al. Usefulness of MR imaging-derived thermometry and dosimetry in determining the threshold for tissue damage induced by thermal surgery in rabbits. Radiology. 2000 Aug;216(2):517–523. PubMed PMID: 10924580; eng.
  • Helfield B, Chen X, Watkins SC, et al. Biophysical insight into mechanisms of sonoporation. Proceedings of the National Academy of Sciences of the United States of America. 2016 Sep 6;113( 36):9983–9988. PubMed PMID: 27551081; PubMed Central PMCID: PMCPMC5018802. eng.
  • Carson AR, McTiernan CF, Lavery L, et al. Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res. 2012 Dec 1;72(23):6191–6199. PubMed PMID: 23010078; PubMed Central PMCID: PMCPMC3654825. eng.
  • Miller DL. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog Biophys Mol Biol. 2007 Jan-Apr;93(1–3):314–330. PubMed PMID: 16989895; eng.
  • Kremkau FW. Cancer therapy with ultrasound: a historical review. J of clin ultrasound: JCU. 1979Aug; 7(4): 287–300. PubMed PMID: 112118; eng.
  • Acconcia C, Leung BY, Manjunath A,et al. Interactions between individual ultrasound-stimulated microbubbles and fibrin clots. Ultrasound Med Biol. 2014 Sep;40(9):2134–2150. PubMed PMID: 24882525; eng.
  • Tarapacki C, Kumaradas C, Karshafian R. Enhancing laser thermal-therapy using ultrasound-microbubbles and gold nanorods of in vitro cells. Ultrasonics. 2013 Mar;53(3):793–798. PubMed PMID: 23290827; eng.
  • Feril LB Jr., Kondo T, Zhao QL,et al. Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents. Ultrasound Med Biol. 2003 Feb;29(2):331–337. PubMed PMID: 12659921; eng.
  • Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990 Jan 3;82(1):4–6. PubMed PMID: 1688381; eng.
  • McNabb E, Al-Mahrouki A, Law N, et al. Ultrasound-stimulated microbubble radiation enhancement of tumors: single-dose and fractionated treatment evaluation. PloS One. 2020;15(9):e0239456. PubMed PMID: 32976517; PubMed Central PMCID: PMCPMC7518623. eng.
  • Al-Mahrouki AA, Karshafian R, Giles A,et al. Bioeffects of ultrasound-stimulated microbubbles on endothelial cells: gene expression changes associated with radiation enhancement in vitro. Ultrasound Med Biol. 2012 Nov;38(11):1958–1969. PubMed PMID: 22980406; eng.
  • Goertz DE, Todorova M, Mortazavi O, et al. Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PloS One. 2012;7(12):e52307. PubMed PMID: 23284980; PubMed Central PMCID: PMCPMC3527530. eng.
  • FERIL, Jr. LB Jr., Kondo T. Biological effects of low intensity ultrasound: the mechanism involved, and its implications on therapy and on biosafety of ultrasound. J Radiat Res. 2004 Dec;45(4):479–489. PubMed PMID: 15635256; eng.
  • Li S, Xu HX, Wu CT,et al. Angiogenesis in pancreatic cancer: current research status and clinical implications. Angiogenesis. 2019 Feb;22(1):15–36. PubMed PMID: 30168025; eng.
  • Xiong J, Yang Q, Li J,et al. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer. Angiogenesis. 2014 Jan;17(1):37–50. PubMed PMID: 23907365; eng.
  • Unterleuthner D, Neuhold P, Schwarz K,et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis. 2020 May;23(2):159–177. PubMed PMID: 31667643; PubMed Central PMCID: PMCPMC7160098. eng.
  • Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science (New York, NY). 2003 May 16;300(5622):1155–1159. PubMed PMID: 12750523; eng.
  • Kolesnick R, Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene. 2003 Sep 1;22(37):5897–5906. PubMed PMID: 12947396; eng. .
  • Albini A, Tosetti F, Li VW,et al. Cancer prevention by targeting angiogenesis. Nat Rev Clin Oncol. 2012 Sep;9(9):498–509. PubMed PMID: 22850752; eng.
  • Al-Mahrouki AA, Iradji S, Tran WT,et al. Cellular characterization of ultrasound-stimulated microbubble radiation enhancement in a prostate cancer xenograft model. Dis Model Mech. 2014 Mar;7(3):363–372. PubMed PMID: 24487407; PubMed Central PMCID: PMCPMC3944496. eng.